EUVIMEDScopri EUVIMED
Randomisierte kontrollierte StudieOpen access · CC BY-NC-ND 4.0

Faecal and urine metabolites, but not gut microbiota, may predict response to low FODMAP diet in irritable bowel syndrome

Bridgette Wilson, Tokuwa Kanno, Rachael Slater, Megan Rossi, Peter M Irving iD, Miranda C Lomer, Chris Probert iD, A James Mason, Kevin Whelan iD

Alimentary Pharmacology & Therapeutics · 2023

DOI: 10.1111/apt.17609 ↗

At a glance

Randomisierte kontrollierte Studie in Alimentary Pharmacology & Therapeutics, 2023. Written by Bridgette Wilson and 8 co-authors. Institution: Department of Nutritional Sciences, King's College London, London, UK. Major MEDLINE topics: Irritable Bowel Syndrome, Gastrointestinal Microbiome. Cited 30 times so far (Crossref); 45 references. The full text is freely available (open access, CC BY-NC-ND 4.0). Funded by: King’s College London.

AbstractSubjectsDati bibliograficiCiteRelated studies

Abstract (original language)

Background

The low FODMAP diet (LFD) leads to clinical response in 50%–80% of patients with irritable bowel syndrome (IBS). It is unclear why only some patients respond.

Aims

To determine if differences in baseline faecal microbiota or faecal and urine metabolite profiles may separate clinical responders to the diet from non‐responders allowing predictive algorithms to be proposed.

Methods

We recruited adults fulfilling Rome III criteria for IBS to a blinded randomised controlled trial. Patients were randomised to sham diet with a placebo supplement (control) or LFD supplemented with either placebo (LFD) or 1.8 g/d B‐galactooligosaccharide (LFD/B‐GOS), for 4 weeks. Clinical response was defined as adequate symptom relief at 4 weeks after the intervention (global symptom question). Differences between responders and non‐responders in faecal microbiota (FISH, 16S rRNA sequencing) and faecal (gas–liquid chromatography, gas‐chromatography mass‐spectrometry) and urine ( 1 H NMR) metabolites were analysed.

Results

At 4 weeks, clinical response differed across the 3groups with adequate symptom relief of 30% (7/23) in controls, 50% (11/22) in the LFD group and 67% (16/24) in the LFD/B‐GOS group ( p = 0.048). In the control and the LFD/B‐GOS groups, microbiota and metabolites did not separate responders from non‐responders. In the LFD group, higher baseline faecal propionate (sensitivity 91%, specificity 89%) and cyclohexanecarboxylic acid esters (sensitivity 80%, specificity 78%), and urine metabolite profile ( Q 2 0.296 vs. randomised −0.175) predicted clinical response.

Conclusions

Baseline faecal and urine metabolites may predict response to the LFD.

Subjects

MeSH terms (MEDLINE)

Irritable Bowel SyndromeGastrointestinal MicrobiomeHumansRNA, Ribosomal, 16SFODMAP DietFermentationDietDiet, Carbohydrate-RestrictedDisaccharides

Author keywords

FODMAPIBSmicrobiotaprebiotics

Substances

RNA, Ribosomal, 16SDisaccharides

Authors and institutions

  • Department of Nutritional Sciences, King's College London, London, UK.
  • Department of Nutrition and Dietetics, Guys and St Thomas' NHS Foundation Trust, London, UK.
  • King's College London, Institute of Pharmaceutical Science, London, UK.
  • University of Liverpool, Institute of Systems, Molecular and Integrative Biology, Liverpool, UK.
  • Department of Gastroenterology, Guys and St Thomas' NHS Foundation Trust, London, UK.
  • School of Immunology and Microbial Sciences, King's College London, London, UK.

ORCID profiles: Peter M Irving, Chris Probert, Kevin Whelan

Funding

  • King’s College London

Cite

APA

Wilson, B., Kanno, T., Slater, R., Rossi, M., Irving, P. M., Lomer, M. C., Probert, C., Mason, A. J., & Whelan, K. (2023). Faecal and urine metabolites, but not gut microbiota, may predict response to low FODMAP diet in irritable bowel syndrome. Alimentary Pharmacology & Therapeutics. https://doi.org/10.1111/apt.17609

Vancouver

Wilson B, Kanno T, Slater R, Rossi M, Irving PM, Lomer MC, et al. Faecal and urine metabolites, but not gut microbiota, may predict response to low FODMAP diet in irritable bowel syndrome. Alimentary Pharmacology & Therapeutics. 2023. doi:10.1111/apt.17609

BibTeX
@article{Wilson2023,
  author = {Wilson, Bridgette and Kanno, Tokuwa and Slater, Rachael and Rossi, Megan and Irving, Peter M and Lomer, Miranda C and Probert, Chris and Mason, A James and Whelan, Kevin},
  title = {Faecal and urine metabolites, but not gut microbiota, may predict response to low FODMAP diet in irritable bowel syndrome},
  journal = {Alimentary Pharmacology & Therapeutics},
  year = {2023},
  doi = {10.1111/apt.17609}
}
Start for free →